Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers 14, 3, S. 813
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Greifswald
- (wer)
-
Universität Greifswald
- (wann)
-
2022
- Urheber
-
Bekeschus, Sander
Ispirjan, Mikael
Freund, Eric
Kinnen, Frederik
Moritz, Juliane
Saadati, Fariba
Eckroth, Jacqueline
Singer, Debora
Stope, Matthias B.
Wende, Kristian
Ritter, Christoph A.
Schroeder, Henry W. S.
Marx, Sascha
- Beteiligte Personen und Organisationen
-
Hassanein, Ahmed
- DOI
-
10.3390/cancers14030813
- URN
-
urn:nbn:de:gbv:9-opus-60780
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bekeschus, Sander
- Ispirjan, Mikael
- Freund, Eric
- Kinnen, Frederik
- Moritz, Juliane
- Saadati, Fariba
- Eckroth, Jacqueline
- Singer, Debora
- Stope, Matthias B.
- Wende, Kristian
- Ritter, Christoph A.
- Schroeder, Henry W. S.
- Marx, Sascha
- Hassanein, Ahmed
- Universität Greifswald
Entstanden
- 2022
Ähnliche Objekte (12)
FAM72, Glioblastoma Multiforme (GBM) and Beyond
Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
Expressional analysis of glypican 3 and glypican 6 in glioblastoma multiforme (GBM) initiating cells : = Expressionsanalyse von Glypican 3 und Glypican 6 in Glioblastoma multiforme (GBM) initiierenden Zellen
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
GBM LOVE
GBM 530
Development, characterisation, and testing of CNS deliverable TRAIL-receptor agonists for the treatment of Glioblastoma (GBM)
Characterization and optimization of the tumor microenvironment in patient-derived organotypic slices and organoid models of glioblastoma
Gebäudemanagement (GBM) - Neuorganisation
Filmbild GbmH
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
FAM72, Glioblastoma Multiforme (GBM) and Beyond
Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
Expressional analysis of glypican 3 and glypican 6 in glioblastoma multiforme (GBM) initiating cells : = Expressionsanalyse von Glypican 3 und Glypican 6 in Glioblastoma multiforme (GBM) initiierenden Zellen
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
GBM LOVE
GBM 530
Development, characterisation, and testing of CNS deliverable TRAIL-receptor agonists for the treatment of Glioblastoma (GBM)
Characterization and optimization of the tumor microenvironment in patient-derived organotypic slices and organoid models of glioblastoma
Gebäudemanagement (GBM) - Neuorganisation
Filmbild GbmH
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
FAM72, Glioblastoma Multiforme (GBM) and Beyond
Immunomodulatory Effects by Photodynamic Treatment of Glioblastoma Cells In Vitro
Expressional analysis of glypican 3 and glypican 6 in glioblastoma multiforme (GBM) initiating cells : = Expressionsanalyse von Glypican 3 und Glypican 6 in Glioblastoma multiforme (GBM) initiierenden Zellen
Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
GBM LOVE
GBM 530
Development, characterisation, and testing of CNS deliverable TRAIL-receptor agonists for the treatment of Glioblastoma (GBM)
Characterization and optimization of the tumor microenvironment in patient-derived organotypic slices and organoid models of glioblastoma
Gebäudemanagement (GBM) - Neuorganisation
Filmbild GbmH